GLOW 70 mg
Educational recon guide for the VERIX GLOW 70 mg research blend (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg) and total-blend daily unit mapping. Research use only.
Vial
70 mg
Your BAC water
3 mL
Concentration
23.33 mg/mL
Per unit
~233.3 mcg
Frequency
Once daily subcutaneous (multi-week course; some 5 days on / 2 off)
Route
Subcutaneous
Blend composition
Fixed ratio in every draw. Per-draw amounts follow your calculator dose (1.40 mg total blend).
| Component | In vial | Share | Per draw |
|---|---|---|---|
| GHK-Cu | 50 mg | 71.4% | 1 mg |
| BPC-157 | 10 mg | 14.3% | 200 mcg |
| TB-500 | 10 mg | 14.3% | 200 mcg |
Total listed mass 70 mg. Step 2 of the calculator is total blend — not one peptide alone.
Live reconstitution calculator
Defaults match this guide (70 mg + 3 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
Quick-select common research doses (includes 2.5 / 7.5 for dual-agonist ladders) or type any mg / mcg value.
Quick select (mg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
6 units
Volume
0.060 mL
Doses per vial
50
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 6.0 u
Fill one 30-unit U-100 syringe to about 6 units (0.060 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (3 mL BAC → 23.33 mg/mL · 233.3 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Community blend tables often use roughly ~1–4 mg total blend per day for 4–8 weeks. Fixed ratio: every draw is ~71% GHK-Cu, ~14% BPC-157, ~14% TB-500 by mass.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Days 1–14 (intro) | 1.40 mg1,400 mcg | 6.0 u | 0.06 mL≈1.4 mg total · GHK-Cu ~1.0 mg · BPC/TB ~0.2 mg each |
| Days 15–42 (standard) | 2.80 mg2,800 mcg | 12.0 u | 0.12 mL≈2.8 mg total · GHK-Cu ~2.0 mg · BPC/TB ~0.4 mg each |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Higher daily · 4 mg × 28 days | 4 mg4,000 mcg | 17.1 u | 0.17 mLUpper educational blend amount — watch copper share from GHK-Cu |
Supplies planner
Using the guide’s phase ladder (1.4 mg → 2.8 mg per injection (phase ladder)) over a 42-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
3 mL · 23.33 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
42-day course
GLOW 70 mg vials
2 vials
~98 mg mg total peptide over this 42-day course at 1.4 mg → 2.8 mg per injection (phase ladder). Each vial holds 70 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
3 mL BAC per vial × 2 vials = 6.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
42+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~88 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 70 mg GLOW blend vial and bacteriostatic water to reach room temperature.
- Draw 3.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "23.3 mg/mL total — 3 mL BAC").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
- ·GHK-Cu can tinge the solution blue-green — can be normal; discard if cloudy or odd odor.
Protocol notes
- ·TOTAL BLEND milligrams — fixed BPC 10 / GHK-Cu 50 / TB-500 10 ratio in every draw.
- ·Related to KLOW (adds KPV); this GLOW vial has no KPV.
- ·Research use only.
Research context & considerations
GLOW is a three-peptide research blend pairing copper-peptide GHK-Cu with recovery peptides BPC-157 and TB-500. Evidence is component-wise; the triad is not an approved combination drug.
- ·Copper exposure from GHK-Cu share — caution with copper disorders.
- ·Injection-site reactions possible.
- ·Not FDA-approved.
- ·Pregnancy out of scope.
Catalog match
GLOW(BPC 157 10mg+GHK-CU50mg+TB500 10mg)
70mg x 10 vials · from $108